Literature DB >> 16719604

Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring.

Andrew J Levine1, Charles H Hinkin, Sarah Marion, Allison Keuning, Steven A Castellon, Mona M Lam, Marta Robinet, Douglas Longshore, Thomas Newton, Hector Myers, Ramani S Durvasula.   

Abstract

Controversy remains regarding the reliability of methods used to determine adherence to antiretroviral medication in HIV. In this study the authors compared adherence rates of 119 HIV-positive participants during a 6-month study, as estimated via electronic monitoring (EM) and self-report (SR). Adherence for both short (4-day) and long (4-week, or intervisit) periods was examined, as well as factors that underlie discrepancies between EM and SR. Results showed that intervisit EM estimates were consistently lower than those of SR. SR estimates based on shorter periods (4 days) were closer to those of EM. Higher discrepancies between EM and SR estimates were associated with lower cognitive functioning and externalized locus of control. These findings lend support for using both EM and SR methods; however, study design (e.g., length) and other factors (e.g., cognitive status, cost) should be considered. 2006 APA, all rights reserved

Entities:  

Mesh:

Year:  2006        PMID: 16719604     DOI: 10.1037/0278-6133.25.3.329

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  31 in total

Review 1.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

3.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

4.  Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates.

Authors:  M J Reinhard; C H Hinkin; T R Barclay; A J Levine; S Marion; S A Castellon; D Longshore; T Newton; R S Durvasula; M N Lam; H Myers
Journal:  Addict Behav       Date:  2007-04-14       Impact factor: 3.913

Review 5.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

6.  If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.

Authors:  Alissa Davis; Lyailya Sarsembayeva; Valeriy Gulyaev; Sholpan Primbetova; Assel Terlikbayeva; Gaukhar Mergenova; Robert H Remien
Journal:  AIDS Behav       Date:  2019-12

7.  A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES().

Authors:  Yangxin Huang; Hulin Wu; Jeanne Holden-Wiltse; Edward P Acosta
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

8.  The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Authors:  Allison J Applebaum; Laura C Reilly; Jeffrey S Gonzalez; Mark A Richardson; Catherine L Leveroni; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

9.  Factors associated with lack of antiretroviral adherence among adolescents in a reference centre in Rio de Janeiro, Brazil.

Authors:  L F B Filho; S A Nogueira; E S Machado; T F Abreu; R H de Oliveira; L Evangelista; C B Hofer
Journal:  Int J STD AIDS       Date:  2008-10       Impact factor: 1.359

10.  A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

Authors:  Steven J Reynolds; Cissy Kityo; Claire W Hallahan; Geoffrey Kabuye; Diana Atwiine; Frank Mbamanya; Francis Ssali; Robin Dewar; Marybeth Daucher; Richard T Davey; Peter Mugyenyi; Anthony S Fauci; Thomas C Quinn; Mark R Dybul
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.